NantKwest Inc (NK):企業の財務・戦略的SWOT分析

◆英語タイトル:NantKwest Inc (NK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH327397FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, develops natural killer (NK) cell therapies to treat cancer, infectious and inflammatory diseases by harnessing the immune system. The company is developing drugs against Merkel cell carcinoma 2L, non-small cell lung cancer 3L, multiple myeloma, pancreatic, ovarian, gastric and HER2+ breast cancer. It is also evaluating programs targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with severe and high risk moderate infection. NantKwest utilizes NK cell platform to develop haNK cells that improve the cancer cell killing effect of antibodies; taNK cells that incorporate chimeric antigen receptors (CARs) to target tumor-specific antigens on the surface of cancer cells; and t-haNKs, a combination of haNK and taNK to destroy cancer cells. The company operates offices in California and Massachusetts, the US. NantKwest is headquartered in San Diego, California, the US.

NantKwest Inc Key Recent Developments

Mar 09,2021: ImmunityBio and NantKwest Complete Merger
Feb 18,2021: 2021 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Jan 13,2021: NantKwest, ImmunityBio announce positive interim data on survival rates in metastatic pancreatic cancer trials

This comprehensive SWOT profile of NantKwest Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of NantKwest Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

NantKwest Inc – Key Information
NantKwest Inc – Overview
NantKwest Inc – Key Employees
NantKwest Inc – Key Employee Biographies
NantKwest Inc – Key Operational Heads
NantKwest Inc – Major Products and Services
NantKwest Inc – History
NantKwest Inc – Company Statement
NantKwest Inc – Locations And Subsidiaries
NantKwest Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

NantKwest Inc – Business Description
NantKwest Inc – Corporate Strategy
NantKwest Inc – SWOT Analysis
SWOT Analysis – Overview
NantKwest Inc – Strengths
NantKwest Inc – Weaknesses
NantKwest Inc – Opportunities
NantKwest Inc – Threats
NantKwest Inc – Key Competitors

Section 3 – Company Financial Performance Charts

NantKwest Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

NantKwest Inc, Key Information
NantKwest Inc, Key Ratios
NantKwest Inc, Share Data
NantKwest Inc, Major Products and Services
NantKwest Inc, History
NantKwest Inc, Key Employees
NantKwest Inc, Key Employee Biographies
NantKwest Inc, Key Operational Heads
NantKwest Inc, Other Locations
NantKwest Inc, Subsidiaries
NantKwest Inc, Key Competitors
NantKwest Inc, SWOT Analysis
NantKwest Inc, Ratios based on current share price
NantKwest Inc, Annual Ratios
NantKwest Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[NantKwest Inc (NK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teva Pharmaceutical Industries Ltd (TEVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • SMART Medical Systems Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Smart Medical Systems Ltd (Smart) is a medical device company that develops and manufactures gastroenterology and GI endoscopy devices. The company offers products such as inflation systems, platform, naviaid ABC, G-eye, naviaid AB, future naviaid products, controlled withdrawal, and others. …
  • NLC India Ltd (NLCINDIA):電力:M&Aディール及び事業提携情報
    Summary NLC India Limited (NLCIL), formerly Neyveli Lignite Corporation Limited, a Government of India Enterprise, is a mining and power generation company. It operates opencast lignite mines and sources coal to generate electricity. The company generates electricity by using various sources of ener …
  • Underwriters Laboratories Inc.:企業のM&A・事業提携・投資動向
    Underwriters Laboratories Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Underwriters Laboratories Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • CropEnergies AG (CE2):企業の財務・戦略的SWOT分析
    CropEnergies AG (CE2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • High Peak Royalties Ltd (HPR):石油・ガス:M&Aディール及び事業提携情報
    Summary High Peak Royalties Limited (High Peak) is a leading utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The compa …
  • Abeona Therapeutics Inc (ABEO):医療機器:M&Aディール及び事業提携情報
    Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associ …
  • Development Bank of Southern Africa:企業の戦略的SWOT分析
    Development Bank of Southern Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Metalfrio Solutions SA:戦略・SWOT・企業財務分析
    Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report Summary Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Singareni Collieries Co Ltd:企業の戦略・SWOT・財務情報
    Singareni Collieries Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Singareni Collieries Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Life Time Fitness, Inc:企業の戦略・SWOT・財務分析
    Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report Summary Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Accelerate Diagnostics Inc (AXDX):医療機器:M&Aディール及び事業提携情報
    Summary Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, in …
  • Ascendance Biotechnology Inc-医療機器分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Tate & Lyle PLC:企業のM&A・事業提携・投資動向
    Tate & Lyle PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tate & Lyle PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …
  • Anthem Inc (ANTM):企業の財務・戦略的SWOT分析
    Anthem Inc (ANTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ardelyx Inc (ARDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company provides product portfolio such as tenapanor, RDX227675, RDX98940 and RDX013, among others. Its products are used for hyperphosphatemia in …
  • Domtar Corporation:戦略・SWOT・企業財務分析
    Domtar Corporation - Strategy, SWOT and Corporate Finance Report Summary Domtar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Zimnat Group:企業の戦略・SWOT・財務情報
    Zimnat Group - Strategy, SWOT and Corporate Finance Report Summary Zimnat Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Elizabeth Arden, Inc.:企業の戦略的SWOT分析
    Elizabeth Arden, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆